Key Details
Price
$0.05Annual ROE
141.34%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
N/ARecent annual earnings:
N/ANext ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
No data about analysts updates
Screeners with NKGNW included
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
NKGen Biotech Warrants doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Similar stocks
FAQ
- What is the primary business of NKGen Biotech Warrants?
- What is the ticker symbol for NKGen Biotech Warrants?
- Does NKGen Biotech Warrants pay dividends?
- What sector is NKGen Biotech Warrants in?
- What industry is NKGen Biotech Warrants in?
- What country is NKGen Biotech Warrants based in?
- Is NKGen Biotech Warrants in the S&P 500?
- Is NKGen Biotech Warrants in the NASDAQ 100?
- Is NKGen Biotech Warrants in the Dow Jones?
- When does NKGen Biotech Warrants report earnings?
What is the primary business of NKGen Biotech Warrants?
NKGen Biotech, Inc. operates as a clinical-stage biotechnology company that focuses on the development and commercialization of autologous, allogeneic, and CAR-NK natural killer cell therapies. Its lead products include SNK01, an autologous NK cell therapy candidate treatment for neurodegenerative diseases; and SNK02, an allogeneic NK cell therapy, which is in Phase 1 clinical trials for refractory solid tumors. The company has a license agreement with NKMAX. The company was formerly known as NKMAX America, Inc. NKGen Biotech, Inc. was founded in 2017 and is headquartered in Santa Ana, California. NKGen Biotech, Inc. operates as a subsidiary of NKMAX Co., Ltd.
What is the ticker symbol for NKGen Biotech Warrants?
The ticker symbol for NKGen Biotech Warrants is NASDAQ:NKGNW
Does NKGen Biotech Warrants pay dividends?
No, NKGen Biotech Warrants does not pay dividends
What sector is NKGen Biotech Warrants in?
NKGen Biotech Warrants is in the Healthcare sector
What industry is NKGen Biotech Warrants in?
NKGen Biotech Warrants is in the Biotechnology industry
What country is NKGen Biotech Warrants based in?
NKGen Biotech Warrants is headquartered in United States
Is NKGen Biotech Warrants in the S&P 500?
No, NKGen Biotech Warrants is not included in the S&P 500 index
Is NKGen Biotech Warrants in the NASDAQ 100?
No, NKGen Biotech Warrants is not included in the NASDAQ 100 index
Is NKGen Biotech Warrants in the Dow Jones?
No, NKGen Biotech Warrants is not included in the Dow Jones index
When does NKGen Biotech Warrants report earnings?
The date for NKGen Biotech Warrants's next earnings report has not been announced yet